NCT03935165View on ClinicalTrials.gov

Prospective Evaluation of Near-infrared Fluorescence Imaging Use as a Supportive Tool in Deep Infiltrating Endometriosis Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 4, 2016

Primary Completion Date

May 19, 2019

Study Completion Date

May 19, 2019

Conditions
Pelvic EndometriosisEndometriosis Outside Pelvis
Interventions
DRUG

Indocyanine Green

"0.25 mg /(kg BW) Indocyanine Green PULSION®/ VERDYE Diagnostic Green®~\- Indocyanine Green is administered Intravenously"

Trial Locations (1)

00100

Catholic University of Sacred Heart, Rome

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER

NCT03935165 - Prospective Evaluation of Near-infrared Fluorescence Imaging Use as a Supportive Tool in Deep Infiltrating Endometriosis Surgery | Biotech Hunter | Biotech Hunter